Friday, July 31, 2026

Large-Scale Real-World Study Supports Zacubo’s Efficacy and Safety in GERD Treatment

A study shows Onconic Therapeutics' Zacubo significantly improves GERD symptoms in patients unresponsive to existing treatments.

Strengthening U.S.-Korea Nuclear Deterrence: Insights from the 6th NCG Meeting

The U.S. and South Korea held the sixth Nuclear Consultative Group meeting, focusing on nuclear integration and countering North Korea's threats.

Xi Jinping Rolls Out the Red Carpet for Kim Jong Un: A Show of Strength in China-North Korea Relations

Xi Jinping warmly welcomed Kim Jong-un during their first meeting in six years, highlighting their close relationship.

Tag: Investor

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Drug Development Is Inherently Unprofitable, Biotech Industry Warns as Delisting Reform Looms

South Korea's biotech sector faces stricter delisting rules, raising concerns over innovation and funding for drug development.

How Daewoong, Naver, and J&P Medi are Transforming Digital Health: Key Insights from the 2026 Partners Day

The event showcases 10 startups presenting innovations in digital healthcare, focusing on AI, brain health, and business strategies.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

SK Hynix Soars 4% After K-Chips Act Boosts Investor Sentiment

SK Hynix shares rose nearly 4% after the “K-Chips Act” passed, boosting semiconductor tax credits and investor sentiment.

Tech Turmoil: Dow, S&P, and Nasdaq Slip Ahead of Microsoft and Meta Reports

U.S. stock markets fell across the board ahead of Big Tech earnings reports released after the closing bell.

Top News

- Our Sponsors Ad -

Follow us